| Cytokine (pg/mL) | Controls () | Acute patients () | Remission patients () |
| IL-1b | 107,7 [16,4–340,8] | 550,0 [192,0–784,3] | 832,75 [481,9–1 016,0] | IL-2 | 2,3 [1,5–3.0] | 4,3 [3,2–5,4] | 5,5 [4,1–7,7] | IL-5 | 9,0 [3,5–11,8] | 6,4 [3,4–16,0] | 8,0 [4,5–15,6] | IL-6 | 23,5 [17,2–27,3] | 51,8 [22,8–67,3] | 20,3 [12,9–25,3] | IL-8 | 1 415,3 [997,1–2 625,4] | 2 777,0 [611,0–7 382,5] | 4 194,0 [411,9–7 220,9] | IL-12 | 203,2 [120,3–280,0] | 217,5 [137,5–519,5] | 225,8 [69,8–286,1] | GM-CSF | 30,4 [13,5–38,0] | 32,0 [10,2–45,3] | 35,3 [21,6–50,0] | IFN-γ | 2,5 [1,8–3,2] | 3,8 [3,2–4,8] | 2,8 [2,2–4,3] | CXCL10 | 384,9 [265,3–435,4] | 3 660,0 [2 809,5–4 457,5] | 3 685,5 [2 663,5–5 124,0] | TNF-α | 4,6 [3,3–6,2] | 8,5 [5,3–12,0] | 5,0 [3,4–8,6] | IL-4 | 8,5 [6,3–9,1] | 8,7 [7,4–11,7] | 7,1 [6,2–8,4] | IL-10 | 23,9 [17,6–32,4] | 22,0 [16,0–60,0] | 11,8 [5,9–20,3] |
|
|